Immunotherapy Toxicity Guidelines

UK Oncology Nursing Society (UKONS)

Acute management guidelines for the initial management of immune related Adverse Events in cancer patients who are receiving or have received Immunotherapy.

If you have scanned a QR Code for Toxicity Management Guidelines please select from the list below:

National Guidance


Society for Endocrinology Endocrine Emergency Guidance:



Society for Gastroenterology Endorsed Guidance:



Joint British Diabetes Societies for Inpatient Care:


National Guidance


Subsequent Management of Immunotherapy Toxicity Guidance

The Clatterbridge Cancer Centre Liverpool - Subsequent Management Guidelines

A guide for members on the prescribing and monitoring of second-line agents, when used in the management of irAEs because of treatment immune-checkpoint inhibitors. Published by the British Oncology Pharmacy Association (BOPA) in Collaboration with The Immuno-Oncology Clinical Network.

BOPA Drug Monographs for Second-line Agents